Biliary Tract Cancer (BTC)
Oncology·MeSH: Biliary Tract Neoplasms
Prevalence
4.2 / 100K
Incidence
3.0 / 100K/yr
4 drugs in development·3 companies·6 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| ziihera | Zymeworks Inc. (ZYME) |
Compare drugs
Frequently asked questions
How many drugs are in development for Biliary Tract Cancer (BTC)?
BioSniper tracks 4 drugs in development for Biliary Tract Cancer (BTC) across 3 companies.
How many clinical trials target Biliary Tract Cancer (BTC)?
There are 6 clinical trials targeting Biliary Tract Cancer (BTC) tracked by BioSniper.
What is the prevalence of Biliary Tract Cancer (BTC)?
The estimated prevalence of Biliary Tract Cancer (BTC) is approximately 4.2 per 100,000 population.
Deep-dive into Biliary Tract Cancer (BTC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis